Herborium Group IncOTC Pink - Current Information:HBRM
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0001 / 0.0001
- Day Range
- 52 Week Range
- Volume2,578,120
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HBRM |
|---|---|---|
| 09:32 ET | 250000 | 0.0001 |
| 11:36 ET | 2000000 | 1E-06 |
| 11:56 ET | 40000 | 5E-05 |
| 11:58 ET | 150000 | 5E-05 |
| 12:00 ET | 88120 | 0.0001 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Herborium Group Inc | 1.1M | 0.0x | --- |
Endonovo Therapeutics Inc | 918.9K | 0.0x | --- |
Q BioMed Inc | 29.0K | 0.0x | --- |
Hi-Great Group Holding Co | 1.8M | 148.3x | --- |
Entia Biosciences Inc | 3.4K | 0.0x | --- |
Mera Pharmaceuticals Inc | 560.0 | 0.0x | --- |
Company Information
Herborium Group, Inc. is a developer, licensor and marketer of herbal ingredient-based medicines and wellness products. The Company's flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. The Company serves clients worldwide. It is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. In addition to AcnEase, the Company has secured a pipeline of product candidates. The products include protein skin bar and adjunct cutting age skincare products based on stem cell technology. it is also ready for commercialization of new products line of natural sexual health and performance enhancing products for men and women. The Company owns all formulations for its proprietary products.
Contact Information
- Headquarters
- One Bridge Plaza N Suite 275FORT LEE, NJ, United States 07024
- Phone
- 201-849-4431
- Fax
- 866-880-4817
Executives
- President, Chief Executive Officer, Acting Chief Financial Officer, Director
- Agnes Olszewski
- Director
- Max Ansbacher
- Director
- Wayne Danson
- Director and Consultant
- James Gilligan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1M |
|---|---|
Revenue (TTM) | $340.3K |
Shares Outstanding | 10.9B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.35 |
Book Value | $-1.65 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -89.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
